CollPlant Biotechnologies Ltd Ordinary Shares (CLGN)
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company specializing in the development of proprietary plant-based collagen technologies. Utilizing bioengineering processes, the company produces recombinant collagen for use in medical, aesthetic, and tissue engineering applications. Founded in Israel, CollPlant aims to provide advanced biomaterials for wound healing, dermatology, and reconstructive procedures.
Company News
The global tooth regeneration market is expected to grow from $4.5 billion in 2023 to $8.2 billion by 2033, driven by advancements in regenerative medicine and dental technology. However, the market faces challenges such as technological hurdles and regulatory barriers.
Nurix Therapeutics (NRIX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular Dystrophy. TRxADE HEALTH, Inc. (NASDAQ: MEDS) shares jumped 91.9% to $16.20. TRxADE HEALTH issued correction to press release announcing its anticipated c...
These two 3D printing companies are now competitors in the burgeoning 3D bioprinting market.